Gastric Disease Clinical Trial
Official title:
Gastric Emptying: in Vivo Studies in Healthy Volunteers (Using Scrambled Egg and Porridge) to Determine Reliable Normal Ranges
The Investigators institution has used a meal consisting of mashed potato, peas and
Beanfeast (soya mince) for gastric emptying studies for a number of decades. Validation of
the study method was purportedly performed when the study was first implemented at the
hospital, however no historical data has been found. The current normal ranges are also
unsubstantiated. There is scientific justification for this research because in vivo studies
are instrumental to the validation of a new procedure. There is a need for a meal
preparation that is palatable and meets dietary requirements (vegetarian, gluten free
e.t.c.) of patients as the diagnosis depends on ingestion of the radiolabelled meal. In
addition, reliable normal ranges will ensure that the clinical diagnosis is accurate.
Scientific justification extends beyond the local department as publishing the data acquired
will allow other hospitals to adopt the same test meals and normal ranges, leading to
standardisation of the clinical protocol employed across the UK. Since the investigators
institution are recognised as the leading Nuclear Medicine GI centre in the UK and have
previously carried out audits and in vitro testing in the area of gastric emptying, it seems
fit that they should lead the national change in protocol.
The proposed study will involve recruitment of healthy volunteers who will eat a meal
containing 10MBq of a radioactive tracer. They will be subsequently scanned using a gamma
camera with imaging lasting no more than 3 hours in total. Approximately 40 healthy
volunteers (18-70 years old, no history of gastrointestinal problems or other serious health
issues e.g. diabetes and pregnant women are excluded) will be recruited and the studies will
be conducted on site i.e. within the Nuclear Medicine department at City hospital.
After the ingestion and subsequent passage of solid or liquid material into the stomach, the
gastric contents will undergo gastric emptying from the stomach into the intestine. The rate
of gastric emptying can be very variable and will depend on the presence of gastric
pathology or defect, composition and volume of the gastric contents and may even be
influenced by factors such as gender and reproductive status. Gastric motility disorders
such as gastroparesis and dumping syndrome can affect the rate of gastric emptying and thus
warrant the quantitative assessment of emptying. Gastroparesis is a disorder of the stomach
characterised by delayed gastric emptying in the absence of any mechanical obstruction and
can be further categorised based on severity; mild gastroparesis (where symptoms can be
easily controlled), compensated gastroparesis (partial control with use of medication and
dietary adjustments) and gastric failure (symptoms are not controllable). Dumping syndrome
occurs as a result of rapid gastric emptying which is usually associated with hypermotility
of the stomach. It manifests as either early or late dumping syndrome, both of which have
distinct physiological bases and clinical presentations.
Typical symptoms of delayed emptying include nausea, vomiting, abdominal pain and abdominal
fullness after eating whilst diarrhoea, weakness and light headedness after meal times are
common symptoms of rapid emptying. In the Nuclear Medicine department at City Hospital
(Birmingham), patients referred for imaging are usually diabetics suffering from feelings of
bloatedness after eating and occasional vomiting. Most patients studied are clinically
diagnosed with gastroparesis associated with diabetes (where the vagus nerve responsible for
controlling movement of food through the digestive tract stops functioning). Dumping is
rarely reported as there is an effective tablet treatment for the disorder that usually
eases the symptoms. (This includes octreotide therapies which can exert an effect through
various mechanisms such as delaying transit, inhibiting the release of gut peptides and
impaired fluid secretion). If left untreated gastroparesis can make diabetes worse by making
it more difficult to manage blood glucose. Assessment of gastric emptying rate is therefore
an important part of diagnosis.
Gastric emptying scintigraphy is a non-invasive diagnostic tool that is used in Nuclear
Medicine to study the emptying of contents into the stomach. This form of scintigraphic
examination is reproducible, simple to perform, accurate, quantitative and exposes the
patient to only a very small radiation dose. It has been significantly optimised and refined
over the years and is now well established as the standard method for evaluating gastric
emptying. As the 'gold standard' gastric emptying scintigraphy is usually the first stage of
the diagnostic journey for a patient, although some may have had a prior endoscopy (usually
in cases of severe vomiting).
The procedure is known to vary between institutions, however will usually involve binding of
a radiotracer to a solid or liquid meal which is then administered orally. This is followed
by positioning of the patient in front of a camera and continuous or intermittent imaging is
performed. Data is acquired over a length of time (usually 1-2 hours) and the data
subsequently analysed to determine the half emptying time (i.e. the time required for the
stomach to empty 50% of the ingested meal) which is then compared to established normal
ranges (i.e. normal emptying rate expected for healthy individual). The current radioactive
meal used for the study consisting of mashed potato, peas and Beanfeast (soya mince) is not
particularly palatable, does not meet the dietary requirements of some patients (e.g.
gluten/wheat free) and is difficult to prepare. In addition, in-house in vitro studies have
found the current meal to be inferior to other meal preparations. Subjecting the radioactive
meal to simulated conditions of the stomach has found that the radiolabel retention was
significantly better in other meals such as scrambled egg and porridge.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02105506 -
Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses
|
N/A | |
Completed |
NCT03198871 -
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
|
Phase 4 | |
Not yet recruiting |
NCT06212206 -
PillBotâ„¢ - Remotely Controlled Capsule Endoscopy
|
N/A | |
Not yet recruiting |
NCT03092414 -
Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions
|
N/A | |
Completed |
NCT03776916 -
Application of Simethicone in Esophagogastroscopy
|
N/A | |
Not yet recruiting |
NCT06273319 -
The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications
|
N/A | |
Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
Completed |
NCT01322737 -
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
|
N/A | |
Completed |
NCT04111393 -
Transoral Removal of Specimen During Laparoscopic Gastric Resection
|
||
Recruiting |
NCT05249933 -
Pronase Granules in Gastric Cleaning
|
Phase 2/Phase 3 | |
Completed |
NCT04479423 -
The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy
|
N/A | |
Completed |
NCT05392452 -
Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
|
N/A | |
Not yet recruiting |
NCT05801055 -
A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone
|
Phase 3 |